Purple Biotech
PPBT
8 hedge funds and large institutions have $1.04M invested in Purple Biotech in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
6,853% more capital invested
Capital invested by funds: $15K → $1.04M (+$1.03M)
700% more funds holding
Funds holding: 1 → 8 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.16M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$150K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$130K |
| 4 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$80.1K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
+$80.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $725K | +$1.16M | +116 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $93K | +$150K | +15 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $80K | +$130K | +13 | New |
|
|
MC
4
Menta Capital
San Francisco,
California
| $50K | +$80.1K | +8 | New |
|
|
FAAS
5
First Allied Advisory Services
San Diego,
California
| $46K | +$80.1K | +8 | New |
|
6
Jane Street
New York
| $35K | +$60.1K | +6 | New |
|
7
UBS Group
Zurich,
Switzerland
| $8K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $4K | +$10K | +1 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
|
10
Citigroup
New York
| – | -$1K | – | – |
|
PPBT Hedge Fund Activity: Q2 2016 in Review
8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q2 2016, worth a combined $1.04M — up 6,853% from $15K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PPBT positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.16M. The largest seller was Citigroup, cutting an estimated $1K.
- 8 institutional investors held Purple Biotech (PPBT) as of Q2 2016, up from 1 in Q1 2016.
- Funds reported $1.04M of Purple Biotech stock for Q2 2016, up 6,853% quarter-over-quarter.
- 7 funds opened new Purple Biotech positions in Q2 2016 and 0 closed out, a net change of +7 holders.
- The largest Purple Biotech buyer in Q2 2016 was Sabby Management, an estimated $1.16M added.
- The largest Purple Biotech seller in Q2 2016 was Citigroup, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2016.